Osinib 80 mg Tablets

Introcution to Osinib 80mg Tablet Osinib 80mg, Manufactured by Drug International Ltd. Osinib 80mg contains Osimertinib, a powerful third-generation EGFR tyrosine kinase inhibitor. This drug is specifically used to treat patients with non-small cell lung cancer (NSCLC) that carry mutations in the epidermal growth factor receptor (EGFR), including the T790M mutation, which often leads to immune to prior EGFR-targeted therapies. Osinib Osimertinib 80mg works by blocking the abnormal activity of EGFR proteins that drive the uncontrolled growth of cancer cells, thereby helping to slow down or stop the progression of the cancer. It is commonly prescribed as a first-line treatment for metastatic NSCLC or for patients who have not responded to other EGFR inhibitors. Always follow the patient’s doctor’s instructions when taking Osinib 80mg to ensure safe and effective treatment.